TABLE 1.

Baseline Characteristics, Major Morbidity, and Survival

Dexamethasone Group (n = 25)Control Group (n = 25)
Gestational age, wk28.2 (25–31)28.4 (25–30)
Birth weight, g940 (590–1250)940 (610–1250)
Sex ratio (M/F)14/1113/12
Antenatal steroids13 (52)11 (44)
Patent ductus arteriosus13 (52)17 (68)
Intraventricular hemorrhage >grade 25 (20)6 (24)
Periventricular leucomalacia2 (8)2 (8)
Septicemia8 (32)7 (28)
Necrotizing enterocolitis2 (8)3 (12)
Retinopathy of prematurity >grade 29 (36)8 (32)
Survivors at 28 d25 (100)25 (100)
Survivors at discharge23 (92)22 (88)
CLD at 28 d11 (44)*24 (96)*
Ventilated at 28 d4 (16)13 (52)
Oxygen therapy at 36 wk3:23 (13)17:23 (73.9)
  • Values expressed as median (range) or number (percent).

  • * P = .0001; OR 0.336 (95% CI: 0.202–0.559).

  • P < .02; OR 0.175 (95% CI: 0.046–0.662).

  • P < .0001; OR 0.052 (95% CI: 0.011–0.244).